US Patent Issued to TOKYO INSTITUTE OF TECHNOLOGY, SBI PHARMACEUTICALS on Oct. 7 for "Conjugate and cancer therapeutic agent" (Japanese Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,857, issued on Oct. 7, was assigned to TOKYO INSTITUTE OF TECHNOLOGY (Tokyo) and SBI PHARMACEUTICALS Co. LTD. (Tokyo).

"Conjugate and cancer therapeutic agent" was invented by Nobuhiro Nishiyama (Tokyo), Takahiro Nomoto (Tokyo), Kana Kohmoto (Tokyo), Hiroyasu Takemoto (Tokyo) and Makoto Matsui (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "A conjugate is provided in which a deferoxamine-type compound, which is at least one compound selected from the group consisting of deferoxamine or an ion or salt thereof, and a derivative thereof, and a biocompatible polymer are conjugated, where the biocompatible polymer contains a first biocompatible poly...